Holen Sie sich die Stockscreener-App
145.12
0.03%
-0.18
Schlusskurs vom Vortag:
$145.30
Offen:
$145
24-Stunden-Volumen:
414.26K
Relative Volume:
0.11
Marktkapitalisierung:
$30.66B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-25.50
EPS:
-5.69
Netto-Cashflow:
$-868.57M
1W Leistung:
+7.98%
1M Leistung:
+33.65%
6M Leistung:
+90.41%
1J Leistung:
+98.16%
1-Tages-Spanne:
$144.10
$146.84
1-Wochen-Bereich:
$134.19
$146.84
52-Wochen-Spanne:
$60.40
$146.84
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
145.03 | 28.77B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
400.04 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.68 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
714.32 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.39 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Key resistance and support levels for Insmed IncorporatedQuarterly Growth Report & Capital Efficient Trading Techniques - Newser
Is Insmed Incorporated forming a reversal patternTrade Signal Summary & Growth Oriented Trading Recommendations - Newser
Live market analysis of Insmed IncorporatedShare Buyback & Step-by-Step Trade Execution Guides - Newser
Analyzing net buyer seller activity in Insmed IncorporatedWeekly Trend Summary & Real-Time Stock Movement Alerts - Newser
Sentiment analysis tools applied to Insmed IncorporatedWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Chart based exit strategy for Insmed IncorporatedEarnings Beat & Risk Controlled Stock Alerts - Newser
Is Insmed Incorporated still worth holding after the dip2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Analyzing drawdowns of Insmed Incorporated with statistical toolsRecession Risk & Community Consensus Trade Signals - Newser
Insmed (INSM) Soars 6.76% After FDA Approves Brinsupri for Non-CF Bronchiectasis - AInvest
Will Insmed Incorporated outperform small cap indexesWeekly Trade Review & AI Forecast for Swing Trade Picks - khodrobank.com
Insmed (INSM) Surges 6.76% on Bullish Technical Signals Faces Key Resistance at $140 - AInvest
Is Insmed Incorporated stock forming a cup and handleMarket Sentiment Summary & Entry Point Confirmation Alerts - khodrobank.com
Why United Just Catapulted 39%, Pulling Two Rivals With It - Investor's Business Daily
Brinsupri Boost: Is Insmed Stock Undervalued? - StocksToTrade
What high frequency data says about Insmed Incorporated2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Insmed Stock Soars: Buy or Hold Timeout? - timothysykes.com
Insmed Stock Jumps: What’s Driving Change? - StocksToTrade
What analysts say about Insmed Incorporated stockEarnings Risk Report & Growth Focused Stock Pick Reports - khodrobank.com
Buy Rating for Insmed: Promising Market Potential and Strategic Advancements in TPIP Development - TipRanks
Will earnings trigger a reversal in Insmed IncorporatedWeekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Insmed Surges 5.9% on Intraday Rally: What’s Fueling the Momentum? - AInvest
Custom watchlist performance reports with Insmed Incorporated2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
S&P 500 Futures Decline in Premarket Trading; Insmed, Millrose Properties Lead - Barron's
Should you wait for a breakout in Insmed IncorporatedJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Combining price and volume data for Insmed IncorporatedWeekly Loss Report & High Conviction Trade Alerts - Newser
Is Insmed Incorporated forming a double bottomJuly 2025 Technicals & Long-Term Growth Stock Strategies - khodrobank.com
Signal strength of Insmed Incorporated stock in tech scanners2025 Momentum Check & Weekly Breakout Watchlists - Newser
What Fibonacci levels say about Insmed Incorporated reboundJuly 2025 Setups & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Insmed IncorporatedWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Published on: 2025-09-01 13:30:18 - beatles.ru
Is this a good reentry point in Insmed IncorporatedTrade Ideas & Expert Curated Trade Ideas - Newser
Analyzing Insmed Incorporated with risk reward ratio chartsJuly 2025 Sector Moves & High Win Rate Trade Tips - Newser
Intraday pattern recognizer results for Insmed IncorporatedQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Predicting Insmed Incorporated trend using moving averagesBreakout Watch & Verified Technical Trade Signals - Newser
Will Insmed Incorporated Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - thegnnews.com
Is Insmed Incorporated stock entering bullish territoryEarnings Summary Report & AI Forecast Swing Trade Picks - Newser
Exit strategy if you’re trapped in Insmed IncorporatedTrade Volume Summary & Short-Term High Return Ideas - Newser
Will Insmed Incorporated outperform the marketMarket Trend Review & Precise Buy Zone Tips - Newser
How sentiment analysis helps forecast Insmed IncorporatedQuarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Relative strength of Insmed Incorporated in sector analysis2025 Market Sentiment & Community Driven Trade Alerts - Newser
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.08%
2.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):